Regulatory update on sBLA for four-dose Heplisav-B regimen for adults on hemodialysis in the US – Dynavax Technologies
Dynavax Technologies Corporation provided a regulatory update for the Company’s supplemental Biologics License Application (sBLA) to include a four-dose Heplisav- B vaccine [Hepatitis B Vaccine (Recombinant),Adjuvanted] regimen for… read more.
